Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Sales (2016 - 2025)

Historic Return on Sales for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to 2.47%.

  • Vanda Pharmaceuticals' Return on Sales fell 23800.0% to 2.47% in Q4 2025 from the same period last year, while for Dec 2025 it was 1.02%, marking a year-over-year decrease of 9300.0%. This contributed to the annual value of 1.02% for FY2025, which is 9300.0% down from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Return on Sales of 2.47% as of Q4 2025, which was down 23800.0% from 0.4% recorded in Q3 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Return on Sales ranged from a high of 0.14% in Q2 2021 and a low of 2.47% during Q4 2025
  • For the 5-year period, Vanda Pharmaceuticals' Return on Sales averaged around 0.19%, with its median value being 0.02% (2023).
  • Per our database at Business Quant, Vanda Pharmaceuticals' Return on Sales skyrocketed by 1600bps in 2023 and then plummeted by -23800bps in 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Return on Sales (Quarter) stood at 0.1% in 2021, then rose by 2bps to 0.11% in 2022, then tumbled by -149bps to 0.05% in 2023, then plummeted by -75bps to 0.09% in 2024, then tumbled by -2573bps to 2.47% in 2025.
  • Its Return on Sales stands at 2.47% for Q4 2025, versus 0.4% for Q3 2025 and 0.52% for Q2 2025.